| Name | Title | Contact Details |
|---|
Biosculpture Technology is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since opening its doors in 1957, Southeast Health has provided for the changing healthcare needs of the growing communities it serves which includes about 600,000 residents neighboring communities and counties of Southeast Alabama, Southwest Georgia and the Florida Panhandle. Our progress represents the culmination of distinguished service by dedicated board members, physicians, employees and volunteers, and a supportive community. It takes more than technology and a modern facility to treat people. It takes a team of dedicated, well-trained professionals to continually deliver quality healthcare. Employing about 2,500, Southeast Health is recognized as one of the largest employers in the region and is proud of its reputation of providing a positive and responsive work environment. Southeast Health`s medical staff consists of more than 225 active members and just over 400 total members either board certified or board prepared in specialties representing virtually every area of medicine. Through innovation and sustained performance, Southeast Health, a 420-bed regional referral center, has achieved the reputation of providing the best diagnostic, clinical, surgical and patient care services available in the region.
J Sterling Industries is a Woodbridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Olympus-Gyrus ACMI is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Olympus-Gyrus ACMI is based in Memphis, TN. You can find more information on Olympus-Gyrus ACMI at www.gyrusacmi.com
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.